FDA defends Shuren’s tenure after report raises ethics concerns

The FDA backed Jeff Shuren, the agency’s former device leader, amid questions raised by The New York Times. Still, a spokesperson said the FDA has advised Shuren to take greater caution in managing recusal obligations.